Health

Health

Approximately 30% of patients with COVID-19 develop long-term illness

The analysis shows that individuals with diabetes, a higher BMI, or a history of hospitalization are more likely to have this condition. Nearly 30% of individuals treated for COVID-19 developed well-known post-acute sequelae, also known as COVID-19 long, according to new study results from UCLA.1 In addition, individuals with diabetes, a high body mass index, …

Approximately 30% of patients with COVID-19 develop long-term illness Read More »

The asthma drug montelukast (Singulair) can block the crucial COVID protein, reducing viral replication

Targeting Nsp1 with montelukast (Singulair) helps prevent the arrest of host protein synthesis. Credit: Muhammed Afsar Oral medications for asthma and allergy can bind to the essential protein it produces[{” attribute=””>SARS-CoV-2 virus, and reduce viral replication in human immune cells, according to a new study by researchers at the Indian Institute of Science (IISc). Approved …

The asthma drug montelukast (Singulair) can block the crucial COVID protein, reducing viral replication Read More »